1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Prophylaxis: new trials by email Literature Review of Prophylaxis trials Research Report on Prophylaxis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long Term Safety Study of BCX7353 in Hereditary Angioedema BCX7353 - Hereditary Angioedema, HAE | Phase 2 / Phase 3 | Completed | BioCryst Pharmaceuticals | 387 | 2018-02-16 | 2023-06-18 |
Angioedema (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hereditary Complement Deficiency Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Primary Immunodeficiency Diseases (1) · Skin Diseases (1) · Skin Diseases, Vascular (1) · Skin and Connective Tissue Diseases (1) · Urticaria (1) · Vascular Diseases (1)
berotralstat (1)
Australia (1) · Austria (1) · Denmark (1) · France (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Israel (1) · Italy (1) · New Zealand (1) · North Macedonia (1) · Poland (1) · Serbia (1) · Slovakia (1) · South Africa (1)
PMID 34161665, PMID 35820771, PMID 36408587, PMID 38006972, PMID 38020288, PMID 40490218